Fuqiang Wang Selected Research

glaucocalyxin A

1/2022	Corrigendum to Glaucocalyxin A suppresses inflammatory responses and induces apoptosis in TNF-a-induced human rheumatoid arthritis via modulation of the STAT3 pathway [Chem. Biol. Interact. 2021 May 25; 341 109451].
5/2021	Glaucocalyxin A suppresses inflammatory responses and induces apoptosis in TNF-a-induced human rheumatoid arthritis via modulation of the STAT3 pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fuqiang Wang Research Topics

Disease

20	Neoplasms (Cancer) 01/2022 - 06/2011
7	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2016
4	Neoplasm Metastasis (Metastasis) 08/2020 - 01/2019
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2020
3	Carcinogenesis 07/2019 - 01/2016
2	Myasthenia Gravis 07/2022 - 03/2018
2	Rheumatoid Arthritis 01/2022 - 05/2021
2	Thymoma (Thymic Carcinoma) 01/2022 - 12/2020
2	Nasopharyngeal Carcinoma 01/2020 - 12/2016
2	Lymphoma (Lymphomas) 01/2020 - 02/2018
2	Gestational Diabetes (Gestational Diabetes Mellitus) 11/2016 - 12/2015
2	Body Weight (Weight, Body) 09/2015 - 10/2014
2	Stomach Neoplasms (Stomach Cancer) 05/2015 - 01/2015
1	Diabetes Complications 08/2022
1	Fibrosis (Cirrhosis) 04/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Lymphatic Metastasis 01/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Hyperplasia 05/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Vascular System Injuries 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 08/2020
1	Pathologic Constriction (Stenosis) 12/2019
1	Autolysis 06/2019
1	Thymus Neoplasms (Thymus Neoplasm) 03/2018
1	Esophageal Neoplasms (Esophageal Cancer) 01/2018
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 09/2017
1	Colonic Neoplasms (Colon Cancer) 02/2017
1	Disease Progression 02/2017
1	Pathologic Processes 01/2017
1	Endometrial Neoplasms (Endometrial Cancer) 01/2017
1	Cerebral Hemorrhage 01/2017
1	Pediatric Obesity 11/2016

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2009
7	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2012
6	Biological ProductsIBA 01/2018 - 12/2014
4	Peptides (Polypeptides)IBA 01/2022 - 01/2017
3	Long Noncoding RNAIBA 11/2019 - 01/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 12/2016
2	glaucocalyxin AIBA 01/2022 - 05/2021
2	Competitive Endogenous RNAIBA 01/2022 - 11/2019
2	Pharmaceutical PreparationsIBA 08/2020 - 11/2018
2	LuciferasesIBA 01/2019 - 01/2016
2	LuciferinsIBA 01/2018 - 01/2017
2	ProteomeIBA 01/2013 - 07/2010
1	LigandsIBA 08/2022
1	Advanced Glycation End ProductsIBA 08/2022
1	QuercetinIBA 04/2022
1	Alkaline PhosphataseIBA 01/2022
1	Estrogen Receptor alphaIBA 01/2022
1	pyreneIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2022
1	AlkaloidsIBA 05/2021
1	CytokinesIBA 05/2021
1	SterolsIBA 01/2021
1	Enoxacin (AT 2266)FDA Link 08/2020
1	Adenosine Triphosphatases (ATPase)IBA 01/2020
1	VaccinesIBA 01/2020
1	ATP dependent 26S protease (26S proteasome)IBA 01/2020
1	Deubiquitinating EnzymesIBA 01/2020
1	Sincalide FDA Link 01/2020
1	Messenger RNA (mRNA)IBA 11/2019
1	MicroRNAs (MicroRNA)IBA 11/2019
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 07/2019
1	HydrolasesIBA 06/2019
1	SugarsIBA 06/2019
1	EnzymesIBA 06/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	MethyltransferasesIBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	N-nitroso-N-methyltyramine (NNMT)IBA 01/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019
1	Histones (Histone)IBA 01/2019
1	Oncogene Proteins (Oncogene Protein)IBA 01/2019
1	ChromatinIBA 01/2019
1	Nicotinamide N-MethyltransferaseIBA 01/2019
1	AntibodiesIBA 11/2018
1	sulphorapheneIBA 02/2018
1	EstersIBA 01/2018
1	VimentinIBA 01/2018
1	Hypochlorous Acid (Hypochlorite)IBA 01/2017
1	benzoylhydrazineIBA 01/2017
1	Cell-Free Nucleic AcidsIBA 12/2016
1	AmidesIBA 01/2016

Therapy/Procedure

5	Therapeutics 01/2022 - 05/2015
4	Esophagectomy 12/2019 - 01/2018
3	Radiotherapy 09/2017 - 04/2014
2	Neoadjuvant Therapy 01/2022 - 08/2020
2	Thoracotomy 01/2021 - 12/2019
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2020 - 01/2018
1	Thymectomy 07/2022
1	Adjuvant Chemoradiotherapy 01/2021
1	Catheters 01/2021
1	Hysterectomy 01/2020
1	Immunotherapy 01/2020
1	Operative Surgical Procedures 03/2018
1	Neck Dissection (Radical Neck Dissection) 09/2017